Topical Caffeine for Hair Loss: Szendzielorz 2025
This is a plain-language summary of the original published research. We do not add conclusions or opinions of our own. This is not medical advice — consult a certified healthcare practitioner before making any decision.
Original research published in Healthcare, 2025
Caffeine as an Active Ingredient in Cosmetic Preparations Against Hair Loss: A Systematic Review of Available Clinical Evidence
Study conclusion
Every one of the 9 clinical trials reviewed reported that topical caffeine helped with hair loss. But the quality of that evidence is very weak: 5 of the 9 studies were rated very low quality because they had no control group, no randomisation, and did not report the caffeine concentration being used. Three studies were medium quality. Without well-controlled trials, it is not possible to conclude whether the benefit is from caffeine specifically or from other factors.
Strength of evidence
Based on a systematic review of 9 clinical trials using GRADE scoring. 5 studies rated very low quality, 1 low, 3 medium. Major flaws include absence of randomisation and placebo/control groups in most studies. All studies reported positive results, raising concern about publication bias. No meta-analysis was performed.
Who it applies to
Who was studied
People with androgenetic alopecia, excessive hair loss, or hair thinning. Total participants across all 9 studies: 684. Studies included men and women, though most studies enrolled primarily men.
Who was NOT studied
People with other types of hair loss. No study directly compared topical caffeine against minoxidil, finasteride, or other established treatments in a controlled setting. Long-term outcomes were not assessed.
What to look for when shopping
All studies used topical caffeine products (shampoos, solutions, or serums applied directly to the scalp). Caffeine concentration was not consistently reported, which the reviewers flagged as a major gap. Outcomes measured included hair density, hair count, hair shaft diameter, and investigator assessments.
What research cannot help you decide
Whether topical caffeine is effective as a standalone treatment. The optimal caffeine concentration. Whether results hold up in controlled trials with placebo comparisons. Whether topical caffeine is as effective as or complementary to minoxidil or finasteride.
Key findings
- All 9 included clinical trials reported results in favour of topical caffeine for hair loss.
- Evidence quality was very low in 5 studies, low in 1, and medium in only 3.
- The main flaws identified were: no randomisation, no placebo or control group, and no reporting of caffeine concentration.
- No study compared topical caffeine directly against an established hair loss treatment.
- The consistent positive findings across all studies may partly reflect publication bias rather than a robust treatment effect.
- No serious adverse events were reported in the included studies.
What they did
The researchers searched PubMed, Scopus, and Web of Science for clinical trials on topical caffeine products for hair loss, published up to November 29, 2024. 1,121 articles were identified; 9 ultimately met the inclusion criteria. Evidence quality was rated using the GRADE system. No meta-analysis was performed because the studies were too varied to combine statistically.
What they found
| Comparison | Result | Significant? |
|---|---|---|
| Overall direction of results across all 9 studies | All 9 studies reported outcomes in favour of topical caffeine | Yes |
| Evidence quality: GRADE very low | 5 of 9 studies rated very low quality | No |
| Evidence quality: GRADE medium | 3 of 9 studies rated medium quality | No |
| Adverse events | No serious adverse events reported across any study | No |
Limitations
- 1.5 of 9 studies were rated very low quality evidence by GRADE due to absence of randomisation and control groups.
- 2.All studies reported positive results, raising concern about publication bias.
- 3.Caffeine concentration was not consistently reported, making it impossible to identify an effective dose.
- 4.No meta-analysis was performed due to heterogeneity between studies.
- 5.No study compared topical caffeine against minoxidil, finasteride, or other established treatments.
- 6.Long-term outcomes were not assessed.
Who funded it
Not reported. No conflicts of interest declared by the authors.
Used in these articles
Links added as fact-checks and articles citing this study are published.